18566519. BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS simplified abstract (THE JOHNS HOPKINS UNIVERSITY)
BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS
Organization Name
Inventor(s)
Deok-Ho Kim of Seattle WA (US)
Chia-Yi Su of Baltimore MD (US)
Alice Burchett of Deer Park WA (US)
Marcus Williams of Baltimore MD (US)
BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS - A simplified explanation of the abstract
This abstract first appeared for US patent application 18566519 titled 'BIOMIMETIC SYSTEMS AND DISEASE ANALYSIS METHODS
Simplified Explanation: The patent application describes the use of cells and/or organoids for patient diagnosis, drug development, and personalized medicine, particularly for cancer and associated diseases. It also involves a phase-specific and force-guided polymerization of biomaterial to create a model.
Key Features and Innovation:
- Use of cells and organoids for patient diagnosis and personalized medicine.
- Phase-specific and force-guided polymerization of biomaterial.
- Focus on cancer and associated diseases.
Potential Applications: This technology can be applied in:
- Patient diagnosis
- Drug development
- Personalized medicine
- Cancer treatment
Problems Solved:
- Improved patient diagnosis
- Enhanced drug development
- Personalized treatment options for cancer patients
Benefits:
- More accurate diagnosis
- Tailored treatment plans
- Better outcomes for cancer patients
Commercial Applications: This technology has potential commercial uses in:
- Biotechnology companies
- Pharmaceutical industry
- Healthcare sector
Prior Art: Readers can explore prior research on:
- Cell-based diagnostics
- Biomaterial polymerization techniques
Frequently Updated Research: Stay informed about the latest advancements in:
- Organoid technology
- Cancer treatment strategies
Questions about the Technology: 1. How does this technology improve patient diagnosis compared to traditional methods? 2. What are the specific advantages of using cells and organoids in drug development and personalized medicine?
Original Abstract Submitted
Assay and systems are provided that include use of cells and/or organoid for patient diagnosis, drug development, and personalized medicine, including for diagnosis and treatment of cancer and associated diseases and disorders. In one aspect, systems and methods include applying a phase-specific and force-guided polymerization of a biomaterial, wherein the polymerization comprises a nucleation phase and an elongation phase; thereby, producing a model.